What's new

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised

Mar 26, 2025 - 17:05
 0
Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

Makary confirmed as FDA commissioner

Next Article

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab,...

Related Posts

Release notes - production release version 1.7.2514-3 -...

Mar 21, 2025  0

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 6, 2025  0